CPT code 82950 represents a timed blood glucose test used to measure blood sugar levels at specified intervals after a patient ingests a glucose load. This diagnostic laboratory procedure is a core clinical tool for evaluating glucose tolerance and monitoring diabetes care across outpatient and ambulatory settings. Nationally, the code matters because timely and standardized glucose testing informs diagnosis, treatment decisions, and quality measurement for diabetes — a high-prevalence, high-cost chronic condition.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of the clinical purpose of the code, typical sites of service, and the payer landscape that affects coverage and claim handling. The publication also outlines common billing modifiers relevant to laboratory services and highlights areas where policy updates or coverage nuances can affect claims processing and reimbursement.

This summary equips clinicians, billing professionals, and policy analysts with an understanding of the clinical context, coding intent, and payer considerations tied to CPT code 82950. Data not available in the input are noted where applicable in other sections.